Insights - Fennec (FENC) announced that their Phase 3 results, initially released back in October 2017 (read more), were published in the June 21, 2018 issue of the New … Continue Reading
Read nowInsights - Selecta announced updated data on their 3+2 dosing for Phase 2 this morning. This data is not all that relevant because the company has said … Continue Reading
Read nowInsights - GBT released their EHA poster for sickle cell disease adolescent patients this morning. The stock is trading down more than 10% on this release, presumably … Continue Reading
PremiumInsights - Yesterday, GBT released their EHA abstract, which included some top-line data from the 900mg cohort of Part B in Phase 2a adolescent. Here are the key … Continue Reading
Read nowDigital Conferences - TRANSCRIPT OF EVENT Deniel Mero Welcome to PropThink’s First-Ever Digital Conference. My name is Deniel Mero, Editor of PropThink. I will be hosting today’s event. … Continue Reading
Read nowInsights - Global Blood Therapeutics (GBT) Phase 3 Part A data should be out sometime in the next month (read about timeline here). GBT is expected to report … Continue Reading
Premium
